131 related articles for article (PubMed ID: 12817074)
1. LDL-apheresis and immunoadsorption: novel methods in the treatment of renal diseases refractory to conventional therapy.
Sułowicz W; Stompór T
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v59-62. PubMed ID: 12817074
[TBL] [Abstract][Full Text] [Related]
2. An update on LDL apheresis for nephrotic syndrome.
Raina R; Krishnappa V
Pediatr Nephrol; 2019 Oct; 34(10):1655-1669. PubMed ID: 30218191
[TBL] [Abstract][Full Text] [Related]
3. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.
Muso E
Clin Exp Nephrol; 2014 Apr; 18(2):286-90. PubMed ID: 24535024
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
[No Abstract] [Full Text] [Related]
6. Application of LDL-apheresis and immunoadsorption in kidney diseases.
Sułowicz W; Stompór T
Rocz Akad Med Bialymst; 2004; 49():127-34. PubMed ID: 15631328
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.
Kawasaki Y; Suzuki S; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki J; Suzuki H; Hosoya M
Pediatr Nephrol; 2007 Jun; 22(6):889-92. PubMed ID: 17277952
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
Oto J; Suga K; Matsuura S; Kondo S; Ohnishi Y; Inui D; Imanaka H; Kagami S; Nishimura M
J Anesth; 2009; 23(2):284-7. PubMed ID: 19444573
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients.
Al-Mousily MF; Nicoara O; Selewski DT; Nadig S; Twombley K
J Clin Apher; 2022 Aug; 37(4):411-414. PubMed ID: 35238425
[TBL] [Abstract][Full Text] [Related]
10. Apheresis for Kidney Disease.
Furuichi K; Wada T
Contrib Nephrol; 2018; 196():188-193. PubMed ID: 30041226
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS).
Muso E; Mune M; Yorioka N; Nishizawa Y; Hirano T; Hattori M; Sugiyama S; Watanabe T; Kimura K; Yokoyama H; Sato H; Saito T
Clin Nephrol; 2007 Jun; 67(6):341-4. PubMed ID: 17598368
[TBL] [Abstract][Full Text] [Related]
12. Change of chylous ascites during low-density lipoprotein apheresis in a patient with idiopathic nephrotic syndrome.
Iwazu Y; Komori S; Nagata D
Ther Apher Dial; 2015 Feb; 19(1):97-8. PubMed ID: 25256915
[No Abstract] [Full Text] [Related]
13. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
Iwahori T; Yoshida M; Sugiura M; Ioya N; Kawaguchi M
Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
[TBL] [Abstract][Full Text] [Related]
14. A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis.
Kamijo Y; Kaneko Y; Ichikawa T; Kobayashi N; Koyama T; Kakegawa T; Kamijo H; Kono K; Minami S; Tanaka N; Arakura H; Hirata M; Higuchi M; Kiyosawa K; Hora K
Ther Apher; 2002 Dec; 6(6):459-62. PubMed ID: 12460411
[TBL] [Abstract][Full Text] [Related]
15. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
[TBL] [Abstract][Full Text] [Related]
16. Updated evidence of beneficial effect of LDL apheresis for refractory nephrotic syndrome due to a variety of causative diseases for nationwide and global approval.
Muso E; Kakita H; Suzuki H; Tsukamoto T
Ther Apher Dial; 2023 Dec; 27(6):987-999. PubMed ID: 37593995
[TBL] [Abstract][Full Text] [Related]
17. [LDL-apheresis for refractory nephrotic syndrome].
Muso E
Nihon Jinzo Gakkai Shi; 2010; 52(7):928-33. PubMed ID: 21077343
[No Abstract] [Full Text] [Related]
18. Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis.
Araki H; Ono S; Nishizawa Y; Deji N; Nakazawa J; Morita Y; Kume S; Chin-Kanasaki M; Isshiki K; Araki S; Arimura T; Maegawa H; Uzu T
Intern Med; 2015; 54(17):2213-7. PubMed ID: 26328649
[TBL] [Abstract][Full Text] [Related]
19. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
[TBL] [Abstract][Full Text] [Related]
20. Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis.
Sugawara Y; Honda K; Katagiri D; Nakamura M; Kawakami T; Nasu R; Hayashi A; Shintani Y; Tojo A; Noiri E; Kurokawa M; Fukayama M; Nangaku M
Intern Med; 2016; 55(19):2831-2836. PubMed ID: 27725544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
